CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer PatientsJames M. Rae, Mitch Dowsett, Jacklyn N. Thibert et al.|JNCI Journal of the National Cancer Institute|2012Cited by 257
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J. Higgins, Vered Stearns, Tatiana M. Prowell et al.|Breast Cancer Research and Treatment|2011Cited by 64